Orthofix Medical Inc. (OFIX) Stock Score, Valuation & Financial Research

Orthofix Medical Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 18/100.

Quick answer for OFIX

Orthofix Medical Inc. currently has a Wall Street Score of 18/100. The stored market price is $8.93. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.

What Orthofix Medical Inc. does

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies phys

OFIX financial snapshot

Wall Street Score:
18/100
Current price:
$8.93
Market capitalization:
$361.0M
Revenue:
$825.4M
Net income:
$-60.0M
Free cash flow:
$-1.3M
Cash:
$120.3M
Total debt:
$234.4M
EPS:
-2.28
Financial score:
25/100
Valuation score:
0/100
Revenue score:
23/100

What stands out

  • Reported year-over-year revenue growth is +0.0%.
  • Free cash flow is $-1.3M, showing cash burn in the current stored period.
  • The balance sheet shows $120.3M of cash versus $234.4M of total debt, so leverage deserves attention.

What the numbers mean

Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-07-24.

How to research OFIX

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.